Watch Ticker

Sage Therapeutics, Inc

Go to Sage Therapeutics, Inc Website

$11.99

(%)

Live

Previous Close

$11.99

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$721.6 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates

Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.

Related tickers: BIIB, LGND, ANIP, SAGE.

Read Full Article

Zacks Equity Research - Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates

Sage Therapeutics (SAGE) delivered earnings and revenue surprises of -10.43% and 28.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: SAGE, RVMD.

Read Full Article

Trending Tickers

CYTO

XNAS

$1.44

(%)

LASE

XNAS

$2.24

(%)

MGAM

XNAS

$0.02

(%)

SXTC

XNAS

$1.11

(%)

MLGO

XNAS

$0.00

(%)